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Thymus-derived lymphocytes have been shown to carry out three major immuno- 
logical functions--helper function in antibody formation, production of soluble media- 
tors, and cell-mediated cytotoxicity. The relationships between the cells involved in 
these three phenomena and their mechanisms of action remain unknown. This study 
was undertaken to explore whether a relationship exists between mediator production 
and  T-cell-mediated cytolysis, both  manifestations of cell-mediated immunity.  Ex- 
periments were specifically designed to test the hypothesis that T-cell-mediated cyto- 
lysis is effected by a  soluble mediator, produced by the sensitized lymphocyte upon 
interaction with an antigen-bearing ("target") cell (1,  2). The experimental basis for 
this hypothesis derives principally from demonstrations that both antigen and T-cell 
mitogens can stimulate lymphocyte populations to produce soluble factors which are 
toxic for certain cell types in vitro  (3,  4).  Under these same conditions, direct cell- 
mediated cytotoxicity may also be observed (5). The total lack of specificity demon- 
strated in such cytotoxic systems stands in marked contrast to the exquisite specificity 
observed in T-cell-mediated lysis (6, 7). Nevertheless, it is conceivable that the specific- 
ity of T-cell killing resides in the interaction between effector and target cell; i.e. that 
lymphocytes, activated by membrane associated antigens, "inject" nonspecific media- 
tors only into the membrane of the "triggering" target cell (8, 9). Thus,  the mecha- 
nism of lysis in all cases could be similar. 
A number of experimental observations are consistent with the concept that media- 
tor production may be related to the mechanism of T-cell-mediated lysis. For example, 
production of migration inhibitory factor (MIF) 1 (10)  and lymphotoxin (LT)  (1)  is 
suppressed by inhibitors of protein synthesis, and  T-cell-mediated cytolysis is sub- 
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1cAMP,  cyclic  AMP;  Con  A,  concavalin  A;  CT,  cholera  enterotoxin;  LT,  lympho- 
toxin; MIF, migration inhibitory factor; PPD, purified protein derivative (tuberculin). 
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stantially diminished  by cycloheximide and  actinomycin D  (11).  Further,  inhibition 
of DNA synthesis affects neither the production  of mediators by sensitized lympho- 
cytes (12,  13),  nor the lyric activity of effector T  cells (14). 
Recent observations  made in  this  laboratory  (9,  15,  16)  and  in others  (17), 
suggest  that  the expression of lytic activity is dependent  on functional  cellular 
secretion.  While  the  evidence for this  conclusion  is  circumstantial,  when  con- 
sidered  collectively, it seems  compelling.  Cytolysis is  inhibited  by  augmented 
cyclic  AMP  (cAMP)  (15),  by  colchicine  (16,  17),  and  by  both  EDTA  and 
EGTA  (14,  18).  These  agents  have  consistently  been  observed  to  modulate 
secretory phenomena  in  a  wide variety of cell types  (19).  The striking inverse 
relationship  between  cAMP  levels and  cytolysis is perhaps  the  most  insistent 
argument  that  T-cell-mediated cytolysis may  involve secretory  processes. 
Materials and Methods 
Reagents.--Pactamycin  was  a  generous  gift  from.  Dr.  William  Wechter  (Upjohn  Co., 
Kalamzaoo,  Mich.). Cholera enterotoxin  (CT) was a  gift from  Dr.  Richard  A.  Finkelstein 
(The University of Texas, Dallas, Texas).  Emetine and  colchicine were purchased  from the 
Sigma Chemical Co., St. Louis, Mo. Vinblastine was obtained from Eli Lilly  &  Co.,  Indian- 
apolis, Ind. 
Lymphocyte _Populations.  Mouse  splenic  lymphocyte  suspensions  were  prepared  from 
normal C57BL/6 mice and from mice immunized 10 days previously with P815 mastocytoma 
cells of the DBA/2 strain by methods previously described (11, 15). Guinea pig lymph node 
cells from tuberculin-sensitive animals were obtained 3-6 wk after immunization with 1.5 mg 
of killed H37Ra (Difco Laboratories, Detroit, Mich.) emulsified  in Freund's incomplete adju- 
vant as previously described (20). 
Target Cells.--Mouse  mastocytoma cells (P815  of the DBA/2 strain)  were maintained  in 
ascitic fluid in adult DBA/2 female mice, and were used  both as immunizing antigens and as 
target cells in cytolytic assays.  The cells were passaged at weekly intervals by intraperitoneal 
administration of 0.2  ml ascitic fluid  (approximately  107 cells).  Target cells containing 51Cr 
were prepared as described previously (11, 21). 
Cytolytlc A ssays.--The cytolytic assay employed throughout this study was that previously 
described (11, 21). Lymphocytes (107) and target cells (105) were incubated for 4 h at 37°C in 
Eagle's medium containing 10% fetal calf serum. 
At the end of incubation the cells were centrifuged and  the  5act content of an aliquot of 
cell-free supernate counted. The percentage of the 51Cr originally cell associated which was 
released into the supernate on incubation was equated with the percent target cell lysis (11). 
The percent  specific  cytolysis was  evaluated  by  subtracting  from  the  lysis obtained  with 
immune  C57BL/6 lymphocytes that  amount  of  ~lCr released  in  the presence of the same 
number of normal C57BL/6 spleen cells (9). In assessment of the inhibitory activity of various 
reagents employed in these studies, the specific cytolysis recorded in the presence of inhibitor 
was evaluated as a percentage of that specific  lysis observed in the absence of inhibitor. As 
previously described (21), cytolysis as measured in this manner was highly reproducible, and 
populations of lymphocytes harvested 10 days after similar immunization schedules exhibited 
a cytolytic activity that varied only of the order of 10¢~. Replicate analyses performed at the 
same time on an individual lymphocyte population showed standard deviations of <  4- 2.5%. 
MIF Assays.--Guinea  pig lymph node cells were cultured in 1.5 ml Eagle's MEM in the 
absence of serum for 18 h at 22.5 X l0 s viable cells/Leighton tube at 37°C under an atmosphere 
of 7.5(7o CO2 in balanced air. For studies  utilizing pactamycin,  emetine, vinblastine, and  col- C.  S.  HENNEY~  J.  GAFFNEY~  AND  B.  R. -BLOOM  839 
chicine, supe~nates were dialyzed against saline and then wat¢c t~ remove drug, Iyophilized  i 
and  reconstituted with  MEM  containing  15%  heated  guinc~ pig  strum.  For  experiments 
employing CT, which is partially nondialyzable  , supernates were frozen at  -80°C,  thawed, 
and reconstituted with 15% heated guinea pig serum. 
In all experiments to be described, several types of controls were included: (a) lymphocytes 
cultured in the absence of antigen, to which antigen was restored upon harvesting the cells; 
and (b) lymphocytes cultured in the absence of antigen but in the presence of the drug  (to 
which antigen was restored upon harvesting the supernates). 
Experimental samples included:  (a)  cultures stimulated with purified  protein derivative 
(tuberculin) (PPD) (25/zg/ml); (b) cultures stimulated with PPD in the presence of the drug; 
and  (c)  cultures stimulated with PPD  (to which the drug was added  upon harvesting the 
supernate). This latter control was particularly important in the studies on CT, in which the 
CT was found to exert some effect on the indicator macrophages. For calculation of the indices 
of  migration,  two  formulae were  used:  (a)  without  drug,  (migration of  PPD  supernate)/ 
(migration of MEM supernate [-{-PPD]) X  100; and (b) with drug, (migration of PPD super- 
nate with drug)/(migrafion of MEM supernate with drug [-}-PPD])  X  100. Brackets denote 
materials added to supernates after culture and removal of cells). 
In other experiments, lymphocytes were "pulsed" for ]  h with drug; washed three times, 
and then cultured with or without antigen. Formula (b) was then used to calculate migration 
inhibition. In general, it should be noted that the drugs exertedno inhibitory activity on the 
migration of normal guinea pig macrophages. 
LT.--The same supernates assayed for MIF activity were assayed for the presence of LT. 
The culture fuids  were  millipore filtered  (0.44/z) and  placed  on monolayers of  105 L  cells 
grown on Linbro plates  (16-mm  tissue culture,  Linbro  Chemical  Co.,  New  Haven, Conn.) 
in Eagle's medium containing 10%  inactivated fetal calf serum.  After  incubation  for 72  h 
the cell monolayers were washed, and the cells cultured for an additional 4  h  in the presence 
of  1 /~Ci of [3H]leucine.  The incorporation of [3H][eucine into material insoluble in 5% TCA 
was then measured. 
Assays for  Protein  Synthesis.  Lymphocytes  (107/ml)  were  suspended  in  leucine-free 
Eagle's  medium  supplemented with  nonessential amino acids and  incubated  at  37°C  in  a 
humid atmosphere of 10% CO2 in air. For short-term cultures (less than 6 h) 1 #Ci of [3H]leu- 
cine  (>40  Ci/mmol  sp  act:  Schwarz/Mann  Div.,  Becton,  Dickinson  &  Co.,  Orangeburg, 
N. Y.) was included in the culture. For long term cultures (6 h or longer) 2 #Ci of [3H]leucine 
(2 Ci/mmol sp act: Schwarz/Mann Div., Becton, Dickinson & Co.) was added. At the end of 
the incubation period, 4 ml of 5% TCA was added to the culture and the tubes were centrifuged 
at 1,000  X g for 10 rain. The supernate was discarded and the pellets were resuspended in 5 ml 
of TCA and recentrifuged. The final pellets were resuspended  in  1 ml of  tissue solubilizer 
(NCS, Amersham/Searle Corp.,  Arlington Heights, Ill.) which was then incorporated into a 
toluene scintillation cocktail (Liquifluor, New England Nuclear, Boston, Mass.) before count- 
ing. 
cAMP.--The cAMP content of spleen cell suspensions was kindly measured by Dr. Eliza- 
beth Gillespie of Johns Hopkins University by the method of Brown et al. (22). The adaptation 
of this method to lymphoid cell suspensions has previously been described in detail (15,  23). 
RESULTS 
Effect of Inhibitors of Protein Synthesis on  T-Cell-Mediated  Cytolysis and  on 
MIF Production.--Spleen  cell suspensions  from normal  C57BL/6 mice  were 
cultured in vitro in  the presence of [~H]leucine  and  the incorporation of the 
isotope  into  cell-associated protein  assayed  4  and  18  h  later.  The  effect of 
adding various concentrations of the protein inhibitors pactamycin or emetine 840  RELATION  OF MEDIATORS  TO T-CELL-MEDIATED  CYTOLYSIS 
to the culture medium was assessed.  Data for the  18-h  cultures are shown in 
Fig. 1. Both pactamycin (10-7-10  -~ M) and emetine (10-8-10  -5 M) were found 
to totally inhibit [3H]leucine incorporation by the spleen cell suspensions. Vital 
dye exclusion tests performed at  the end of culture showed that  in  the con- 
centrations employed, the drugs did not affect cell viability. The inhibition of 
amino acid incorporation in 4-h cultures was similar (results not shown). Addi- 
tionally, protein synthesis by a human lymphoblastoid line (8866) was similarly 
suppressed  by  pactamycin  over  the  same  range,  10-8-10  -5  M  (results  not 
shown).  The drug effects, in  all cases,  were largely irreversible; cells treated 
with inhibitor at 37°C for 30-60 rain and then washed, showed a suppression 
of protein synthesis over an  18-h period comparable to that observed in cells 
cultured continuously in the presence of drug. 
Pactamycin  and  emetine  both  markedly  suppressed  the  T-cell-mediated 
destruction of DBA/2 mastocytoma cells by spleen cell suspensions from allo- 
immunized C57BL/6 mice. Effector spleen cell populations were incubated at 
37°C for 1 h  in Eagle's medium containing various concentrations of emetine 
or pactamycin. The spleen cell suspensions were then washed three times, and 
lymphoid cells added to 5~Cr-labeled DBA/2 mastocytoma cells at a 100:1 ratio. 
As can be seen (Fig.  1), both pactamycin and emetine at concentrations of 
10  -5 M  totally inhibited cytolysis, apparently demonstrating the dependence 
of the lyric event on continuous protein synthesis. The concentration of inhibi- 
tors employed did not affect 51Cr release from target cells in  the presence of 
normal C57BL/6 spleen cells.  It will be noted (Fig.  1)  that emetine and pac- 
tamycin both totally inhibited amino acid incorporation at concentrations as 
low as 10-  7 M; cytolysis at these concentrations was only minimally suppressed. 
A  detailed analysis of this discordance will  be the subject of a separate com- 
munication. 
Guinea pig lymph node ceils treated with pactamycin or with emetine also 
showed a  diminished capacity to produce MIF when stimulated with specific 
antigen  (Fig.  1).  Lymph node cells obtained from animals  exhibiting strong 
delayed hypersensitivity skin reactions to PPD, were treated for 1 h  at 37°C 
with  pactamycin  (10-  ~ M)  or emetine  (10-  s M)  and were  then  washed  and 
incubated with  25 #g/ml  PPD.  Under these conditions MIF production was 
abolished. Treatment of sensitized lymphocytes for 24 h with lower concentra- 
tions of drug was associated with a dose-dependent inhibition of MIF produc- 
tion,  which,  from a  quantitative  standpoint,  paralleled closely the effects of 
inhibitor dilution of [3H]leucine incorporation (Fig. 1), particularly seen in the 
case of emetine (Fig.  1 b). 
The  Effects  of In  Vitro  Treatment  of Lymphoid  Cells  with  CT  on  T-Cell- 
Mediated  Cytolysis and  on MIF and LT Production.--Because  pharmacologic 
agents which increase intracellular cAMP have been shown to suppress T-cell- 
mediated cytotoxicity (15,  24), several such drugs were tested for their effect 
on LT and MIF production. In initial studies, dibutyryl cAMP and theophyl- C.  S.  HENNEY~  J.  GAFFNEYj  AND  B.  R.  BLOOM  841 
z 
i.- 
-i- 
x 
I- 
X 
w 
rr 
LI_I 
13.. 
I00 -~ 
80. 
60 
40 
20 
AA Incorp "/t~1 
/ 
/ 
i  / 
I  x  Cy%olysis 
i I 
i I  d' 
10-7  1~)'6  10"5 
PACTA  MYCIN  (molar) 
I00 
80 
Z 
40 
a_  20 ~ 
Cytolysis 
@ 
IG-7  It)'6  10-5 
EMETINE (moJor) 
Fro.  1.  Effect of the protein synthesis inhibitors (a)  pactamycJn and  (b)  emetine on the 
amino acid incorporation and the specific (anti-DBA/2)  cytolytic activity of C57BL/6 mouse 
spleen cells and on PPD-induced  MIF production by guinea pig lymph node cells. For details 
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line were found to be without effect, while prostaglandin  E1 was occasionally 
inhibitory.  Because  the  cytotoxicity assay  requires  less  time  than  the  16  h 
necessary to  produce MIF  and  LT, we  chose to  study  the  effects of CT,  a 
potent  and  protracted  adenylate  cyclase-stimulating  agent.  We  have  previ- 
ously shown that cholera toxin can suppress the cytolytic activity of effector T 
cells both in vivo and in vitro; a  suppression presumably mediated via eleva- 
tion of lymphocyte cAMP levels (23,  25). 
Lymph node cells  from PPD-sensitized guinea pigs  were  treated with  100 
ng/ml cholera toxin for 24 h in the presence or absence of 25 #g/ml PPD. Three 
sets of controls were used: (a) cells incubated without antigen (to which  PPD 
was  restored  after  harvesting  the  supernate);  (b)  cells  cultured  with  PPD 
alone; and (c) cells cultured with PPD (to which cholera toxin was added after 
harvesting the supernates). The supernatant fluids were then assayed for MIF 
and  LT;  the  cell  pellets  for  cAMP  content.  Results  from  4  representative 
animals out of over 20 studied are presented in Table I. These animals were 
selected because they were sensitized and  tested on  the same  day,  and  tests 
for LT, MIF, and cAMP were performed in parallel.  It should be noted that 
in other experiments not shown, lymphocytes were cultured for 1 h  with CT, 
washed three times, and then cultured in  the presence or absence of antigen, 
with essentially no effect on mediator production. 
Treatment of mouse and guinea pig lymphocytes with  CT caused marked 
elevation in  cAMP  levels which  persisted  through  a  24-h  incubation  period 
(Table I and references 23 and 25). Elevation of cAMP levels were first demon- 
strable  1-2 h  after treatment with  CT,  and in earlier studies we have shown 
that cAMP remains at an augmented level for 24-48 h  (25). 
Elevated  cAMP  levels  in  mouse  effector cell  populations  were  associated 
with an almost  total inhibition of lytic activity (legend Table I). These data 
have already been described in detail  (15,  23).  On  the other hand, guinea pig 
lymph node cells with augmented cAMP levels produced, on stimulation with 
homologous antigen, amounts of LT equivalent to that produced by untreated 
cells  (Table I).  CT-treated cells which were washed before antigenic stimula- 
tion, produced amounts of MIF comparable to untreated controls. When  CT 
was included throughout the period of culture, however, some suppression of 
MIF activity was noted (Table I). It was apparent that most of this effect was 
at  the level of MIF  action, for the  addition of CT  to  MIF  containing PPD 
supernates  diminished  their  inhibitory  activity  on  the  migration  of  normal 
macrophages,  in  some  cases  dramatically  (animal  4,  Table  I).  Such  findings 
are in concordance with those of Koopman et al. (26). 
Cholera toxin treatment of mouse spleen cells  had no effect on LT produc- 
tion induced by concanavalin A  (Con A)  (Table II).  In  this study,  6  X  108 
C57BL/6 mouse spleen cells were incubated with 100 ng of CT for 1 h, washed, 
and  then cultured for 72 h  in  the presence of 10 ~g/ml  Con A.  The cell-free 
supernates were harvested, millipore filtered (0.44/z  pore size), and  then  cul- C.  S. HENNEY~  J. GAFFNEY,  AND  B. R.  BLOOM  843 
TABLE I 
CT Activation  of Lymphocyte  cAMP Levels: Effect  on MIF and LT Production 
MIF  LT 
Guinea  Culture  conditions*  Lymphocyte  Inhibition of a.a.  pig  cAMP levels$  Inhibition  Inhibition  incorporation 
of mi-  of MIF[I  by LT¶ 
gration§  production 
undild.  1:3 
Inhibition 
of LT pro- 
duction** 
p mol/lO  ? cells  %  %  %  % 
1  Medium alone  9.9; 4.6  0  --  0 
q- PPD~;$  4.6; 4.6  70  --  92.4  50.6  -- 
q- PPD -4-  CT§§  92,3;  168,3  54  23  94.7  78.9  0 
q- PPD  CCT)Illl  9.9; 4.0  63  10  94.8  66.0  0 
2  Medium alone  12..5;  10.6  0  --  0 
-4- PPD  21.2;  27.1  77  --  93.3  69.7  -- 
-]- PPD q- CT  130  55  29  95.8  78.6  0 
+  PPD  (CT)  8.4;  11.2  65  16  94.6  81,8  0 
3  Medium alone  17.1;  14.8  0  --  0 
q- PPD  8.3  .56  --  97.6  26.9  -- 
+  PPD +  CT  205.6;  266.0  41  27  93.5  56.5  0 
+  PPD  (CT)  15.0  46  18  91.2  58.3  0 
4  Medium alone  Not measured  0  --  Not measured 
+ PPD  65  -- 
+  PPD q- CT  19  70 
+  PPD  (CT)  18  72 
Treatment  (1 h, 370C)  of effector T-cell populations with 100 ng/ml of CT suppressed cytolysis 78.5 -4- 14.2%; 
I0 ng/ml inhibited cytolysls 61.2 4- 10.1%; and I ng/m139.5 4- 7.3%. 
* 2.2 X  107 guinea pig lymph node cells obtained 22 days after immunization with complete Freund's adjuvant 
(see text) were cultured  for 24 h  with or without antigen. After culture,  the ceils were separated and suspended 
in 5% TCA and immediately frozen until cAMP measurements were made. The supernates were assayed for MIF 
and LT. 
:~ Number given is mean of triplicate assays on two individual cell samples. Replicates of each sample were 
always <  4- 20% and usually  <  4-  10%. 
§ Relative to inhibition of migration observed in cultures  incubated with CT in the absence of PPD and re- 
constituted with PPD at time of subsequent harvest. Values given for inhibition of migration are means of dupli- 
cate estimations. 
[I Relative to migration inhibition observed in the presence of PPD alone. 
¶  Relative to supernates from cultures  containing lymphocytes but no antigen. 
** Relative to cultures  containing antigen but no drug. 
~$  25  ~g/ml PPD. 
§§ 100 ng/ml CT added to the cultures at the time of antigenic stimulation. 
[[[] Cholera toxin added at time of supernate harvest (after 24-h incubation of cells with PPD alone). 
tured with  105 mouse L cells for 72 h. Destruction of the L-cell monolayer was 
assayed as described in the Materials and Methods. As can be seen (Table II), 
CT-treated cells produced, in the presence of Con A, amounts of LT comparable 
to those obtained from untreated  cells  (Table II). In other experiments,  not 
shown,  100 ng/ml CT was kept in the cultures throughout the period of incuba- 
tion with Con A. The results obtained were similar: the presence of CT had no 
effect on LT production. Thus, under conditions in which the specific cytolytic 
activity of T  cells was almost totally abolished, LT and MIF production  by 
both mouse and guinea pig lymphoid cells remained basically unaffected. 
Effects  of  Colchicine  and  Vinblastine  on  T-Cell-Mediated  Cytolysis  and  on 844  RELATION  OF  MEDIATORS  TO  T-CELL-MEDIATED CYTOLYSIS 
TABLE II 
Effect of Cholera Toxin and Colchicine on PHA-Induced Mouse Lymphotoxin Production 
LT assay 
Cells  Treatment  Inhibition a.a  Inhibition LT 
incorporation  production* 
Exp. I  Exp. II  Exp. I  Exp. II 
C57BL/6 
Spleen 
%  % 
None  0  0 
Con A~t  84.6  83.5  --  -- 
Con A  +  CT§  95.2  77.0  0  8 
Con A (+CT)[[  76.5  78.2  10  6 
Con A +  colchicine¶  83.3  72.3  2  13 
Con A (+ colchicine)**  87.9  84.9  0  0 
Con A +  10  -5 M  0  1.8  100  98 
pactamycin:~: 
6  )<  106 C57BL/6 spleen cells were incubated alone or in  the presence of drugs for 1 h at 
37°C. The cells were then washed three times and cultured with 10 #g/ml Con A for 72 h at 
37°C. The supernates obtained were millipore filtered (0.44/z)  and then placed on  top of  105 
L cells and cultured for a further 72 h. During the last 4 h  of this  culture 1 #Ci[3H]leucine 
was added and the amino acid incorporation into the residual cells then assayed. 
Cholera toxin and eolchicine inhibit T-cell-mediated cytolysis in a  dose-related manner; at 
the  100 ng/ml cholera toxin concentration employed above, we  have observed  79  -4-  12% 
inhibition of specific cytolysis (23) ; 3 X  10-  4 M colchicine inhibited cytolysis 72%. 
* Calculated relative to cultures containing Con A but no drug. 
:~ 10 #g/ml. 
§ Spleen  cells treated with  100 ng/ml cholera  toxin for 1 h at 37°C then washed and in- 
cubated.with Con A. 
[I Cholera toxin (100 ng/ml) added to supernate before assay only. 
¶  Spleen cells treated with 3  X  10  -4 M  colchicine for  1 h  at 37°C and then washed and 
incubated with Con A. 
** Colchicine (3  X  10  --4 M) added  to supernate before assay only. 
:~:~ Cells cultured with 10- 5 M pactamycin at 37°C for 30 rain and  then washed 4-5 times 
before culturing with Con A. The supernate was then assayed for LT activity. 
MIF  and LT  Production.--As  reported earlier (16),  effector spleen cells treated 
for  1  h  at  37°C  with  colchicine  at  concentrations  varying  from  10  -5  to  3  X 
10  -4 M  showed  diminished  lytic  activity.  The  degree of suppression  was  dose 
related  (Table  III).  Vinblastine,  another  antimitotic  agent  with  a  propensity 
for  microtubule  subunits  similar  to  that  shown  by  colchicine  (27),  inhibited 
cytolysis  comparably.  Spleen  cells  treated  with  vinblastine  for  1  h  at  37°C 
were  washed  and  their  lytic  capacity  then  compared  to  untreated  cells.  The 
effects  (Table  III)  were  similar  to  those  observed  with  colchicine,  complete 
inhibition  occurring  after  treatment  of  the  effector  cells  with  concentrations 
of  10  -4  M.  Vinblastine-treated  cells  showed  no  diminished  viability  by  dye 
exclusion  tests.  Treatment  of  target  cells with  colchicine and vinblastine had 
no effect on  their susceptibility  to lysis, nor did the drugs  affect the release of 
5~Cr from  target cells in the presence of normal  C57BL/6  spleen cells. C.  S.  HENNEY, J.  GAFFNEY, AND  B.  R.  BLOOM 
TABLE III 
Effect of Colchicine and  Vinblastine  on T-Cell-Mediated  Cytolysis 
845 
Drug  Specific cytolysis  Inhibition of specific cytolysis 
%  % 
57.1  -¢-  7.0  None 
Colchicine 10  -5 M  27.4  -4- 6.3  52 
10-  4 M  18.8  -4- 5.3  67 
3  >(  10- 4 M  16.0  -4-  6.2  72 
10  -3 M  7.4  -¢- 4.8  87 
None  38.5 
Vinblastine 3 X 10  -7  34.7  10 
10- 6  19.9  48 
3  X  10  -6  13.8  64 
10- 5  8.8  77 
3  ×  10  -5  4.7  88 
10  -4  0.5  99 
107 C57BL/6 spleen cells taken 10 days after immunization  with 107 DBA/2 mastocytoma 
cells were incubated with or without drug for 1 h at 37°C. The cells were then washed and 
their  lytic activity against 105  5ICr-labeled DBA/2  mastocytoma  cells assessed. Percent 
specific cytolysis was calculated after subtraction of the percent 5tCr released in the presence 
of 10  r C57BL/6 spleen cells from unimmunized animals. Percent inhibition  of specific  cytolysis 
was calculated relative to effector cells incubated in the absence of drug. 
The values recorded for colchicine inhibition  are the means 4- standard deviation derived 
from two experiments, in each of which the assays were performed in triplicate. The values 
recorded for vinblastine  are means of triplicate assays in a single experiment. Duplication of 
this experiment gave similar values. 
We had previously observed that vinblastine did not diminish the produc- 
tion  of  MIF  by  viable  PPD-stimulated  guinea pig  lymph  node  cells  (13). 
Similarly, treatment with  colchicine (3  X  10-4  M)  or colcemid for  24 h  had 
little or no effect on the concurrent antigen-induced production of MIF or LT 
(Table IV).  MIF  containing supernates  to  which  vinblastine, colchicine, or 
colcemid were added fully maintained their migration inhibitory activity, e.g. 
PPD supernates, 33.4 %  and 23.2 % inhibition; the same supernates containing 
colcemid  1  #g/ml,  37.9%  and  26.9%.  At  the  same  time,  the  migration of 
normal macrophages was  found to  be markedly increased by the presence of 
both colchicine and vinblastine. 
The production of LT from mouse spleen cells in the presence of Con A was 
unaffected by pretreatment with vinblastine (3)<  10  -5 M)  (results not shown) 
or  colchicine (3  X  10  -4 M)  (Table II),  concentrations which  almost  totally 
inhibited the  lytic activity of  immune T-cells.  LT  action was  similarly un- 
affected by addition of vinblastine or colchicine to active supernates. 846  RELATION  OF  MEDIATORS  TO  T-CELL-MEDIATED CYTOLYSIS 
TABLE IV 
Effect of Colchicine  on LT and MIF Production from Guinea Pig Lymph Node Cells 
LT  MIF 
Exp. 
Inhibition of a.a  Inhibition of macrophage 
incorporation*  Diminution of  mediator  migration* 
production by  PPD + 
PPD  PPD +  colchicine~t  PPD  Colchicine  colchicine 
Diminution of 
MIF production 
by colchicine:[: 
%  %  %  % 
I  92.4  94.8  0  70  63  10 
II  93.3  95.0  0  77  59  23 
IIl  70.7  88.5  0  50  48  4 
IV  87.6  83.2  5  56  46  18 
V  Not tested  33  46  --14 
VI  Not tested  23  37  --14 
Immune guinea pig lymph node cells as described in Table I were cultured for 24 h with 
or without antigen  (25 #g/ml PPD) in the presence or absence of 3 X  10  -4 M  colchicine. 
After culture the cells were separated and the supernates assayed for both  MIF and LT as 
described in the Materials and Methods. 
* Relative to supernates obtained from lymphocytes cultured in the absence of antigen. 
:[: Relative to the mediator produced in cultures containing  antigen but no drug. 
DISCUSSION 
One of the central problems in cellular immunology at the present time con- 
cerns  the  heterogeneity  of T  cells. In  addition  to  differences in  longevity, 
response  to  mitogens  and  circulation  patterns,  T-cell  heterogeneity  is  also 
reflected  in  terms of biological activity. ]t  is  not  vet possible  to  determine 
whether the helper and suppressor activities of T cells are mediated by different 
subpopu]ations  from  those  responsible  for  mediator  production  and  direct 
cytolysis or  whether  a  single T-cell line exhibits different capabilities during 
different stages of its differentiation or maturation. 
Our  attention in  this  paper  has  been  directed  at  the  two  T-cell functions 
most  directly  concerned  with  the  effector  arm  of  cell-mediated  immunity: 
soluble mediator production and T-cell-mediated cytotoxicity. The experiments 
presented were designed to  test  the hypothesis that mediator production and 
T-ceil-mediated  cytolysis  were  necessarily  related  cell-mediated  immune 
phenomena, and that soluble mediators were involved in the lytic mechanism. 
Initial  suggestions  that  mediator  production  and  cell-mediated  cytolysis 
might be related came from observations that both phenomena were suppressed 
b x,  inhibitors of protein synthesis. Production of MIF  (10)  and LT  (1)  were 
shown to be inhibited by puromycin, and T-cell-mediated cytolysis was shown 
to be substantially diminished by cycloheximide and  actinomycin D  (11).  In 
the present studies, pactamycin and emetine, both known to be potent inhibi- 
tors of the initiation of protein synthesis (28,  29), were able to suppress pro- 
duction of MIF, LT,  and T-cell-mediated cytolysis totally at  concentrations 
of 10  .5 M,  confirming the previous observations. However, on analysis of the C.  S.  HENNEY,  J.  GAFFNEY,  AND  B.  R.  BLOOM  847 
dose curves (Fig.  1),  it became clear that mediator production was  consider- 
ably more sensitive  to  inhibition  by  these  agents  than  was  T-cell-mediated 
cytolysis, e.g. at 10  .6 M  pactamycin, cytolysis was inhibited only 20 %, while 
MIF production and  amino  acid incorporation were inhibited approximately 
90%.  Thus,  while  both  MIF  production  and  T-cell-mediated lysis  are  ulti- 
mately affected by pactamycin and emetine, there was a marked dissociation 
in the sensitivities to these drugs.  Furthermore, inhibition of cytolysis did not 
seem to parallel the effect of the drugs on amino acid incorporation. 
Further experimental dissociation of mediator production and T-cell-medi- 
ated cytolysis was observed when the effects of adenylate cyclase-stimulating 
agents were studied. In the present study, CT was employed to ensure poten- 
tiation of cAMP levels throughout the 24- to 48-h period required for mediator 
production. The T-cell-mediated lytic activity of spleen cell populations was 
dramatically inhibited after treatment with  CT, yet augmentation of cAMP 
levels was without effect on the production of guinea pig MIF and LT or murine 
LT.  In  earlier  studies,  Koopman  et  al.  observed  that  cAMP  active  drugs 
inhibited  the  action  of MIF  on  guinea pig macrophages,  but  reported  that 
inhibition of MIF production was only irregularly seen in the presence of iso- 
proterenol or theophylline (26).  While cAMP levels in the lymphocyte popu- 
lations were not assayed in their work, from our earlier studies it would appear 
unlikely  that  augmentation  of cAMP  would  have  persisted  throughout  the 
assay  period.  We  observed  only  a  transient  (10-30  min)  augmentation  of 
lymphocyte cAMP levels by isoproterenol, and no demonstrable elevation with 
theophylline (15). In the present study, we were able to confirm their observa- 
tion that cAMP-active drugs inhibit the action of preformed MIF on guinea 
pig macrophages. Interestingly, CT had no effect on either the production or 
action of LT. The results were unequivocal, and were true of antigen-induced 
LT from guinea pig lymph node cells  as well  as for LT produced by mouse 
spleen cells after Con A stimulation. These findings are at variance with those 
of Lies and Peter (30), who reported that dibutyryl cAMP and theophylline 
diminished  the  production of LT from human  lymphocytes.  In  that  study, 
cAMP levels were not measured, and the drugs chosen would not be expected 
to give prolonged increases in cAMP levels. Additionally, their assay for LT 
involved 51Cr release from DBA/2 mastocytoma cells  after a  16-h incubation 
period. In the present studies, such cells treated with both our guinea pig and 
mouse LT did not cause 5ICr release over this time period. It is conceivable, 
though unlikely, that two different cytotoxic factors are being measured. 
It previously had been reported that vinblastine, while inhibiting cell pro- 
liferation,  had  no  effect  on  MIF  production  by  viable  antigen-stimulated 
guinea pig lymphocytes  (13).  This observation was  confirmed in  this  study, 
and similar findings were also made with colchicine and colcemid. These vinca 
alkaloids were similarly without affect on the production of LT. On the other 
hand, both colchicine and vinblastine were potent inhibitors of T-cell-mediated 848  RELATION  OF  MEDIATORS  TO  T-CELL-MEDIATED  CYTOLYSIS 
cytolysis.  Colchicine and  vinblastine  are,  of course,  antimitotic  agents,  but 
this is  almost certainly not  the mode of inhibition of cytolysis, for the lytic 
process occurs independently of DNA synthesis  (14).  It is known  that  these 
drugs have a propensity for the dimeric subunits of microtubules, and by bind- 
ing  to  them  may  inhibit  microtubular  aggregation  and  thus  interfere with 
secretory processes  (27,  31).  In  this  regard,  it  is noteworthy that  colchicine 
and vinblastine usually inhibit secretion of prepackaged "granules" but gener- 
ally fail to affect continuous secretory processes. Thus, colchicine inhibits the 
secretion of lysosomal enzymes (32)  but not the secretion of immunoglobulin 
from plasma cells (33). 
In summary, we demonstrate here that T-cell-mediated lysis was inhibited 
under  conditions  in  which  synthesis  of  two  lymphocyte-derived mediators 
(LT and MIF)  remain unaffected. While extrapolation from these studies  of 
two  mediators  to  all  possible  products  of  activated  lymphocytes would  be 
unwarranted,  these studies provide no  ground for support of the hypothesis 
that soluble mediators play an essential role in T-cell-mediated cytolysis. Two 
possible objections to this conclusion deserve  address.  Firstly,  it  is  possible 
that the cAMP-active drugs, and colchicine, prevent lymphocyte "triggering" 
by cell-associated antigens, but not  by soluble  antigens,  thus  accounting  for 
the observation that  cytolysis is  inhibited  without  affect on  mediator pro- 
duction. There is,  however, experimental evidence to refute this point.  In a 
previous study we have shown that the specific binding of effector T  cells  to 
specific target cell monolayers was not affected by colchicine or the adenylate 
cyclase  stimulating  hormone,  PGE1,  but  was  inhibited  by  cytochalasin  B 
(34). Thus, the inhibitory activity of colchicine or cAMP stimulating drugs is 
not attributable to an effect on binding. 
Recent demonstrations that both B  and T  cells are able to produce medi- 
ators  (references  35  and  36,  and  footnote 2)  could present  grounds  for  an 
alternative  explanation  of our  observations.  It  could  be  argued  that  T-cell 
mediator production, along with T-cell-mediated cytolysis, could be inhibited 
by colchicine and the cAMP-active drugs,  but that  B-cell mediator synthesis 
could continue. Such arguments would demand either that B and T cells differ 
in the manner in which they synthesized and/or secreted products of activated 
lymphocytes, or, at the least,  that they exhibited marked differences in  sus- 
ceptibility to several distinct classes of pharmacological agents.  To date  the 
effective dose-response  relationships of the vinca alkaloids,  pactamycin and 
emetine, and CT have been observed to be rather similar for a wide variety of 
cell types (19, 28,  29). While there may be differences in susceptibility of B 
and T  cells to one of the drugs used in this study, it is improbable  that differ- 
ences would exist in susceptibility to all. It is perhaps worthy of note that  the 
production of LT by mitogen-stimulated murine spleen cells was almost totally 
2 Bloom, B. R., E. Shevach,  and I. Green. Manuscript in preparation. C.  S.  HENNEY,  J.  GAFFNEY~  AND  B.  R.  BLOOM  849 
inhibited by treatment with anti-thy.l serum and  complement (37), and that 
in the present experiments LT production was unaffected by treatment with 
CT, vinblastine, or colchicine  (Table II). Nevertheless a definitive resolution 
of this problem must await results of experiments carried out on homogeneous 
lymphocyte subpopulations. 
Our findings do not, of course, imply that soluble mediators lack other im- 
portant biological functions in connection with delayed type hypersensitivity 
reactions or with tumor and allograft rejection. While a dissociation between 
cytolytic activity and mediator production under the conditions employed was 
clear, it cannot be argued on the basis of these experiments that these two func- 
tions  are  necessarily carried  out  by  independent  subpopulations  of T  cells. 
This may indeed be the case and a number of recent observations support this 
contention.  Using  TNP-conjugated  mastocytoma  cells  and  fixation  with 
glutaraldehyde, Dennert was able to distinguish between T-helper and T-effec- 
tot cells (38). These same T-cell activities have been selectively inhibited  by 
treatment  with  the  appropriate  anti-Ly  sera  plus  complement  in  mice  (P. 
Kisielow, personal communication). The alternative possibility that mediator 
production  and  cytolytic activity  are  functions  of  the  same  T-cell  line  at 
different  stages  of  maturation  cannot  be  excluded  by  presently  available 
evidence. 
SUMMARY 
Experiments have been designed to test the hypothesis that soluble mediator 
production and T-cell-mediated cytotoxicity are necessarily related phenomena, 
and that soluble mediators may be involved in the mechanism of cytolysis. To 
this  end,  agents  known  to  inhibit  T-cell-mediated  lysis  in  vitro  have  been 
studied  for their effects on  the production of two lymphocyte-derived medi- 
ators, lymphotoxin (LT) and migration inhibitory factor (MIF). 
A  clear dissociation  between  mediator production  and  cell-mediated  cy- 
tolysis  was  found  using  inhibitors  of  protein  synthesis.  Pactamycin  and 
emetine, in doses of 10  -~ M  to 10  -6 M, suppressed production of MIF and LT 
with only slight effect on killing of mastocytoma cells by immune  T  cells. On 
the other hand colchicine and vinblastine inhibited T-cell-mediated cytolysis 
in a dose-related manner but had no significant effect on either MIF or LT pro- 
duction. A striking dichotomy was also observed after augmentation of intra- 
cellular  cyclic  3'5'  adenosine  monophosphate  (cAMP)  levels  with  cholera 
enterotoxin. Increased  cAMP levels were associated with abrogation of direct 
lytic activity, but were without significant effect on MIF or LT production in 
guinea pigs  or mice.  These  findings  indicate  that  mediator  production  and 
direct lymphocyte-mediated cytolysis can be experimentally dissociated and 
represent independent cell-mediated immune  functions. 
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